|
1
|
Stout AP and Murray MR:
Hemangiopericytoma: A vascular tumor featuring Zimmermanns
pericytes. Ann Surg. 116:26–33. 1942. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Begg CF and Garret R: Hemangiopericytoma
occurring in the meninges: case report. Cancer. 7:602–606. 1954.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cushing H and Eisenhardt L: Meningiomas:
Their Classification, Regional Behavior, Life History, and Surgical
End ResultsCharles C Thomas; Springfield, IL: 1938, PubMed/NCBI
|
|
4
|
Giannini C, Rushing EJ and Hainfellner:
HemangiopericytomaIn: WHO Classification of Tumors of the Central
Nervous System. Louis DN, Ohgaki H, Wiestler OD and Cavenee WK:
IARC Press; Lyon: pp. 178–180. 2007
|
|
5
|
Vuorinen V, Sallinen P, Haapasalo H, et
al: Outcome of 31 intracranial hemangiopericytomas: poor predictive
value of cell proliferation indices. Acta Neurochir (Wien).
138:1399–1408. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guthrie BL, Ebersold MJ, Scheithauer BW
and Shaw EG: Meningeal hemangiopericytoma: histopathological
features, treatment, and long-term follow-up of 44 cases.
Neurosurgery. 25:514–522. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chiechi MV, Smirniotopoulos JG and Mena H:
Intracranial hemangiopericytomas: MR and CT features. AJNR Am J
Neuroradiol. 17:1365–1371. 1996.PubMed/NCBI
|
|
8
|
Chen Q, Chen XZ, Wang JM, Li SW, Jiang T
and Dai JP: Intracranial meningeal hemangiopericytomas in children
and adolescents: CT and MR imaging findings. AJNR Am J Neuroradiol.
33:195–199. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dufour H, Métellus P, Fuentes S, et al:
Meningeal hemangiopericytoma: a retrospective study of 21 patients
with special review of postoperative external radiotherapy.
Neurosurgery. 48:756–763. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chang SD and Sakamoto GT: The role of
radiosurgery for hemangiopericytomas. Neurosurg Focus. 14:e142003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kumar N, Kumar R, Kapoor R, et al:
Intracranial meningeal hemangiopericytoma: 10 years experience of a
tertiary care Institute. Acta Neurochir (Wien). 154:1647–1651.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rutkowski MJ, Jian BJ, Bloch O, et al:
Intracranial hemangiopericytoma: clinical experience and treatment
considerations in a modern series of 40 adult patients. Cancer.
118:1628–1636. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stessin AM, Sison C, Nieto J, Raifu M and
Li B: The role of postoperative radiation therapy in the treatment
of meningeal hemangiopericytoma: experience from the SEER database.
Int J Radiat Oncol Biol Phys. 85:784–790. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim JH, Jung HW, Kim YS, et al: Meningeal
hemangiopericytomas: long-term outcome and biological behavior.
Surg Neurol. 59:47–54. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rutkowski MJ, Sughrue ME, Kane AJ, et al:
Predictors of mortality following treatment of intracranial
hemangiopericytoma. J Neurosurg. 113:333–339. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schiariti M, Goetz P, El-Maghraby H,
Tailor J and Kitchen N: Hemangiopericytoma: long-term outcome
revisited. Clinical article. J Neurosurg. 114:747–755. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bastin KT and Mehta MP: Meningeal
hemangiopericytoma: defining the role for radiation therapy. J
Neurooncol. 14:277–287. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fountas KN, Kapsalaki E, Kassam M, et al:
Management of intracranial meningeal hemangiopericytomas: outcome
and experience. Neurosurg Rev. 29:145–153. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Delgado M, Pérez-Ruiz E, Alcalde J, et al:
Anti-angiogenic treatment (sunitinib) for disseminated malignant
haemangiopericytoma: a case study and review of the literature.
Case Rep Oncol. 4:55–59. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kirn DH and Kramer A: Long-term freedom
from disease progression with interferon alfa therapy in two
patients with malignant hemangiopericytoma. J Natl Cancer Inst.
88:764–765. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Domont J, Massard C, Lassau N, et al:
Hemangiopericytoma and antiangiogenic therapy: clinical benefit of
antiangiogenic therapy (sorafenib and sunitinib) in relapsed
malignant haemangioperyctoma/solitary fibrous tumour. Invest New
Drugs. 28:199–202. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Peters KB, McLendon R, Morse MA and
Vredenburgh JJ: Treatment of recurrent intracranial
hemangiopericytoma with SRC-related tyrosine kinase targeted
therapy: a case report. Case Rep Oncol. 3:93–97. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yovine A, Riofrio M, Blay JY, et al: Phase
II study of ecteinascidin-743 in advanced pretreated soft tissue
sarcoma patients. J Clin Oncol. 22:890–899. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Park MS, Patel SR, Ludwig JA, et al:
Activity of temozolomide and bevacizumab in the treatment of
locally advanced, recurrent, and metastatic hemangiopericytoma and
malignant solitary fibrous tumor. Cancer. 117:4939–4947. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tatar Z, Thivat E, Planchat E, et al:
Temozolomide and unusual indications: review of literature. Cancer
Treat Rev. 39:125–135. 2013. View Article : Google Scholar : PubMed/NCBI
|
